Juscelino Tovar1, Maria Johansson2, Inger Björck2. 1. Food for Health Science Centre, Lund University, Medicon Village, 223 81, Lund, Sweden. juscelino.tovar@food-health-science.lu.se. 2. Food for Health Science Centre, Lund University, Medicon Village, 223 81, Lund, Sweden.
Abstract
PURPOSE: A multifunctional diet (MFD) was previously shown to reduce blood lipids, CRP and blood pressure in a 4-week intervention under weight-maintenance conditions. Here, MFD effects were evaluated in an 8-week intervention with no restriction for weight changes. METHODS:Healthy subjects consumed MFD (23 subjects) or acontrol diet (CD) devoid of the functional components (24 subjects) in a "free-living" randomized controlled experiment. MFD included several functional concepts: low-glycemic-impact meals, antioxidant-rich foods, oily fish, viscous dietary fibers, soybean and whole barley kernel products, almonds and plant stanols. Measured outcomes were fasting blood values of lipids, glucose, insulin, GGT, CRP, HbA1c, PAI-1, GLP-1, GLP-2, body weight, blood pressure and breath hydrogen. RESULTS: At baseline, participants were 51-72 years old, with BMI between 25 and 34 and fasting glycemia ≤ 6.1 mmol/L. Consumption of both diets resulted in similar weight loss after 8 weeks (-4 %; P < 0.001). Compared to baseline, consumption of MFD reduced total serum cholesterol (-26 %; P < 0.0001), LDL cholesterol (-35 %; P < 0.0001), triglycerides (-16 %; P < 0.05), LDL/HDL (-27 %; P < 0.0001) and ApoB/ApoA1 (-15 %; P < 0.0001). There were important net differences between diets, which remained significant after adjustment for body weight. Reduced systolic blood pressure, circulatingGGT, HbA1c and insulin concentrations were observed with both MFD and CD with no difference between diets. The Reynolds cardiovascular risk score was decreased by 36 % (P < 0.0001) with MFD. MFD increased breath hydrogen levels (120 %; P < 0.05). CONCLUSIONS: Consumption of MFD decreased blood lipids and improved several other aspects of the cardiometabolic risk profile. This effect was not dependent on weight loss.
RCT Entities:
PURPOSE: A multifunctional diet (MFD) was previously shown to reduce blood lipids, CRP and blood pressure in a 4-week intervention under weight-maintenance conditions. Here, MFD effects were evaluated in an 8-week intervention with no restriction for weight changes. METHODS: Healthy subjects consumed MFD (23 subjects) or a control diet (CD) devoid of the functional components (24 subjects) in a "free-living" randomized controlled experiment. MFD included several functional concepts: low-glycemic-impact meals, antioxidant-rich foods, oily fish, viscous dietary fibers, soybean and whole barley kernel products, almonds and plant stanols. Measured outcomes were fasting blood values of lipids, glucose, insulin, GGT, CRP, HbA1c, PAI-1, GLP-1, GLP-2, body weight, blood pressure and breath hydrogen. RESULTS: At baseline, participants were 51-72 years old, with BMI between 25 and 34 and fasting glycemia ≤ 6.1 mmol/L. Consumption of both diets resulted in similar weight loss after 8 weeks (-4 %; P < 0.001). Compared to baseline, consumption of MFD reduced total serum cholesterol (-26 %; P < 0.0001), LDL cholesterol (-35 %; P < 0.0001), triglycerides (-16 %; P < 0.05), LDL/HDL (-27 %; P < 0.0001) and ApoB/ApoA1 (-15 %; P < 0.0001). There were important net differences between diets, which remained significant after adjustment for body weight. Reduced systolic blood pressure, circulating GGT, HbA1c and insulin concentrations were observed with both MFD and CD with no difference between diets. The Reynolds cardiovascular risk score was decreased by 36 % (P < 0.0001) with MFD. MFD increased breath hydrogen levels (120 %; P < 0.05). CONCLUSIONS: Consumption of MFD decreased blood lipids and improved several other aspects of the cardiometabolic risk profile. This effect was not dependent on weight loss.
Authors: Iris Erlund; Raika Koli; Georg Alfthan; Jukka Marniemi; Pauli Puukka; Pirjo Mustonen; Pirjo Mattila; Antti Jula Journal: Am J Clin Nutr Date: 2008-02 Impact factor: 7.045
Authors: Chad L Cox; Kimber L Stanhope; Jean Marc Schwarz; James L Graham; Bonnie Hatcher; Steven C Griffen; Andrew A Bremer; Lars Berglund; John P McGahan; Nancy L Keim; Peter J Havel Journal: Nutr Metab (Lond) Date: 2012-07-24 Impact factor: 4.169
Authors: Rebecca A Seguin-Fowler; David Strogatz; Meredith L Graham; Galen D Eldridge; Grace A Marshall; Sara C Folta; Kristin Pullyblank; Miriam E Nelson; Lynn Paul Journal: Am J Prev Med Date: 2020-05-07 Impact factor: 5.043
Authors: Irene Alfaras; Clara Di Germanio; Michel Bernier; Anna Csiszar; Zoltan Ungvari; Edward G Lakatta; Rafael de Cabo Journal: Circ Res Date: 2016-05-13 Impact factor: 17.367